Each addition increases complexity, cost, and potential for interactions or side effects
10.3389/fphar.2023.1182113 31 ZhouC.PengS.LinA.JiangA.PengY.GuT.et al (2023)
Each capsule contains 500 mg of Glutathione in its reduced form
The most extensively studied compounds are exenatide (Byetta [Amylin Pharmaceuticals, San Diego, CA], which has been approved by the US Food and Drug Administration [FDA] for the treatment of type 2 diabetes), liraglutide (Victoza [Novo Nordisk, Princeton, NJ], which has been submitted to the FDA for approval), sitaglitptin (Januvia [Abbott Laboratories, Abbott Park, IL], which has been approved by the FDA for type 2 diabetes), and vildagliptin (Galvus [Novo Nordisk, Princeton, NJ], which has been submitted to FDA)
semaglutide is the active ingredient